A Case of Secukinumab in the Treatment of Psoriasis-Like Cutaneous Chronic Graft-versus-Host Disease

Anti-IL-17A monoclonal antibody therapy may represent an alternative treatment modality for cGVHD patients presenting with psoriatic phenotypes.

Authors

Institutions

Publication Details

Journal
Case Reports in Dermatology
Published
2025-10-18
DOI
https://doi.org/10.1159/000548556
Primary Topic
Psoriasis: Treatment and Pathogenesis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Case of Secukinumab in the Treatment of Psoriasis-Like Cutaneous Chronic Graft-versus-Host Disease

Rong Zhu, Yuanchao Li
Case Reports in Dermatology
Psoriasis: Treatment and Pathogenesis
article

A Case of Secukinumab in the Treatment of Psoriasis-Like Cutaneous Chronic Graft-versus-Host Disease

Rong Zhu, Yuanchao Li
article en

Abstract

Anti-IL-17A monoclonal antibody therapy may represent an alternative treatment modality for cGVHD patients presenting with psoriatic phenotypes.

Case Reports in DermatologyVol. 17(1)
Xinqiao Hospital (CN)
Chongqing Science and Technology Commission
Openalex Percentile: Top 69%
Psoriasis: Treatment and Pathogenesis
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Case of Secukinumab in the Treatment of Psoriasis-Like Cutaneous Chronic Graft-versus-Host Disease — Rong Zhu, Yuanchao Li · Case Reports in Dermatology (2025) | TGRS Research Map | TGRS